Cargando…
Positive Allosteric Modulation of CB(1) Cannabinoid Receptor Signaling Enhances Morphine Antinociception and Attenuates Morphine Tolerance Without Enhancing Morphine- Induced Dependence or Reward
Opioid analgesics represent a critical treatment for chronic pain in the analgesic ladder of the World Health Organization. However, their use can result in a number of unwanted side-effects including incomplete efficacy, constipation, physical dependence, and overdose liability. Cannabinoids enhanc...
Autores principales: | Slivicki, Richard A., Iyer, Vishakh, Mali, Sonali S., Garai, Sumanta, Thakur, Ganesh A., Crystal, Jonathon D., Hohmann, Andrea G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199816/ https://www.ncbi.nlm.nih.gov/pubmed/32410959 http://dx.doi.org/10.3389/fnmol.2020.00054 |
Ejemplares similares
-
Inhibition of PSD95‐nNOS protein–protein interactions decreases morphine reward and relapse vulnerability in rats
por: Oliva, Idaira, et al.
Publicado: (2022) -
Morphine Antinociception Restored by Use of Methadone in the Morphine-Resistant Inflammatory Pain State
por: Watanabe, Chizuko, et al.
Publicado: (2020) -
Enhancement of morphine-induced antinociception after electroconvulsive shock in mice
por: Iwata, Ken, et al.
Publicado: (2021) -
Differences in morphine-induced antinociception in male and female offspring born of morphine exposed mothers
por: Biglarnia, Masoomeh, et al.
Publicado: (2013) -
Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
por: Reichenbach, Zachary W., et al.
Publicado: (2022)